ZA908186B - Collagen containing ophthalmic formulation - Google Patents

Collagen containing ophthalmic formulation

Info

Publication number
ZA908186B
ZA908186B ZA908186A ZA908186A ZA908186B ZA 908186 B ZA908186 B ZA 908186B ZA 908186 A ZA908186 A ZA 908186A ZA 908186 A ZA908186 A ZA 908186A ZA 908186 B ZA908186 B ZA 908186B
Authority
ZA
South Africa
Prior art keywords
ophthalmic formulation
collagen containing
containing ophthalmic
collagen
formulation
Prior art date
Application number
ZA908186A
Other languages
English (en)
Inventor
Cherng-Chyi Roger Fu
Roger Fu Cherng-Chyi
Efraim Shek
Shek Efraim
Jeffrey Scott Fleitman
Scott Fleitman Jeffrey
De Mei Chau Leung
Mei Chau Leung De
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ZA908186B publication Critical patent/ZA908186B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA908186A 1989-10-13 1990-10-12 Collagen containing ophthalmic formulation ZA908186B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42142189A 1989-10-13 1989-10-13

Publications (1)

Publication Number Publication Date
ZA908186B true ZA908186B (en) 1992-06-24

Family

ID=23670442

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908186A ZA908186B (en) 1989-10-13 1990-10-12 Collagen containing ophthalmic formulation

Country Status (8)

Country Link
EP (1) EP0422681A1 (xx)
JP (1) JPH03133925A (xx)
KR (1) KR910007511A (xx)
AU (1) AU6454290A (xx)
CA (1) CA2027433A1 (xx)
IE (1) IE903658A1 (xx)
IL (1) IL95942A0 (xx)
ZA (1) ZA908186B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
CA2511217A1 (en) * 2002-12-20 2004-07-15 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
CA2536185C (en) * 2003-08-20 2012-06-26 Santen Pharmaceutical Co., Ltd. Drug delivery system by administrating fine particles to sub-tenon
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US7947267B2 (en) 2004-10-08 2011-05-24 Potentia Pharmaceuticals, Inc. Viral complement control proteins for eye disorders
US8043609B2 (en) 2004-10-08 2011-10-25 Potentia Pharmaceuticals, Inc. Viral complement control proteins for eye disorders
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP3660033B9 (en) 2012-11-15 2022-06-22 Apellis Pharmaceuticals, Inc. Long-acting compstatin analogs and related compositions and methods
WO2014152391A1 (en) 2013-03-15 2014-09-25 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
EP3359555B1 (en) 2015-10-07 2023-12-20 Apellis Pharmaceuticals, Inc. Dosing regimens
CA3059304A1 (en) 2017-04-07 2018-10-11 Apellis Pharmaceuticals, Inc. Dosing regimens and related compositions and methods
CN111420036A (zh) * 2020-04-30 2020-07-17 广州市醒目医药科技有限公司 含有i型胶原和丹参提取物的复合物及制备和应用
CN114831930B (zh) * 2022-03-28 2023-09-05 厦门大学 一种胶原蛋白组装眼药、制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2173736A1 (en) * 1972-02-29 1973-10-12 Avicon Inc Collagen-contg ophthalmic prepns - with prolonged therapeutic effects
JPS597684B2 (ja) * 1976-05-20 1984-02-20 明治製菓株式会社 コラ−ゲンを用いた眼用徐放性制御医薬剤
US4544516A (en) * 1982-07-28 1985-10-01 Battelle Development Corporation Collagen orientation
ES8601706A1 (es) * 1983-05-16 1985-11-16 Merck & Co Inc Una composicion farmaceutica
NZ226100A (en) * 1987-09-11 1990-12-21 Syntex Inc Stabilised ophthalmic formulation containing non-steroidal anti-inflammatory drug

Also Published As

Publication number Publication date
KR910007511A (ko) 1991-05-30
IL95942A0 (en) 1991-07-18
JPH03133925A (ja) 1991-06-07
CA2027433A1 (en) 1991-04-14
AU6454290A (en) 1991-04-18
IE903658A1 (en) 1991-04-24
EP0422681A1 (en) 1991-04-17

Similar Documents

Publication Publication Date Title
ZA908186B (en) Collagen containing ophthalmic formulation
GB8913708D0 (en) Cosmetic composition
GB8918709D0 (en) Cosmetic composition
EP0419148A3 (en) Cosmetic composition
GB9003449D0 (en) Ophthalmological lasers
GB9006201D0 (en) Skin composition
EP0433909A3 (en) Formulation
GB8914791D0 (en) Formulation
ZA906497B (en) Cosmetic composition
GB8917959D0 (en) Pharmaceutical formulation
GB8917217D0 (en) Ophthalmic compositions
GB8917216D0 (en) Ophthalmic composition
IE894065L (en) Ophthalmic formulations
GB8906432D0 (en) Gel formulation
GB8920042D0 (en) Ophthalmic applicator
GB8917792D0 (en) Ophthalmic applicator
GB8812530D0 (en) Ophthalmic composition
GB8908248D0 (en) Formulation
GB8911554D0 (en) Formulation
GB8913170D0 (en) Formulation
GB8926252D0 (en) Formulation
GB8926629D0 (en) Formulation
IE892084L (en) Ophthalmic solutions
GB8830228D0 (en) Novel formulation
GB8830227D0 (en) Novel formulation